Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Colonic Neoplasms × Surgical Procedures, Operative × Clear all

Phase

Status

Sponsor Class

OTHER 10 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 3 Recurrence 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Unresectable Non-small Cell Lung Cancer 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Sexual Dysfunction, Physiological 1 Radiation Injuries 1 Prostatic Neoplasms 1 Pilonidal Sinus 1 Pain, Postoperative 1 Pain 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Intestinal Diseases 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Death 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Adenocarcinoma 1

Interventions

Leucovorin 4 Fluorouracil 3 Oxaliplatin 2 Cetuximab 2 Capecitabine 2 tislelizumab 1 ferric maltol 1 envafolimab 1 Tranexamic Acid 1 Surgical Procedures, Operative 1 Ropivacaine 1 Propofol 1 Preoperative Exercise 1 Positron Emission Tomography Computed Tomography 1 Nitrous Oxide 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Motivational Interviewing 1 Laparoscopy 1 Isoflurane 1 Irinotecan 1 Immunohistochemistry 1 HMPL-013 1 Folfox protocol 1 Filgrastim 1 Fentanyl 1 Epinephrine 1 Endoscopic Mucosal Resection 1 Drug Therapy 1 Curcumin 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06940947 2025-11-20

ETHOS

Norwegian Department of Health and Social Affairs

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡